Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05540080 · ClinicalTrials.gov registry record · NA
Non-invasive Lipolysis and Improvement of Muscle Tone in Lateral Abdomen
A NA study, sponsored by BTL Industries.
- Completed
- Registry status
- NA
- Development phase
- 46
- Enrollment target
NCT05540080 is a NA study that has completed, run by BTL Industries. The registered enrollment target is 46 participants.
The verdict
NCT05540080, a NA study, has completed, sponsored by BTL Industries.
- COMPLETED
- Registry status
- NA
- Development phase
- 46 participants
- Enrollment target
Study Summary
This study will evaluate the clinical efficacy and performance of the BTL-899 device for changes in subcutaneous fat and muscle tissue in the lateral abdomen region (also referred to as flanks or "love handles"). The study is a prospective, multi-center, open-label, single-arm study. The subjects will be enrolled and assigned into a single study group. Subjects will be required to complete four (4) treatment visits and two follow-up visits. All of the study subjects will receive the treatment with the subject device.
Interventions
- DEVICE BTL-899
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 46 participants |
| Start Date | 2022-06-10 |
| Est. Completion | 2023-10-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05540080
The ClinicalTrials.gov registry entry for NCT05540080 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 46 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is BTL Industries, which has 40 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which BTL-899 is the first listed.
NCT05540080 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05540080 about?
NCT05540080 is a clinical study titled "Non-invasive Lipolysis and Improvement of Muscle Tone in Lateral Abdomen". This study will evaluate the clinical efficacy and performance of the BTL-899 device for changes in subcutaneous fat and muscle tissue in the lateral abdomen region (also referred to as flanks or "love handles"). The study is a prospective, multi-center, open-label, single-arm study. The subjects wi...
What is the current status of trial NCT05540080?
This trial is currently completed. It is a NA study. The enrollment target is 46 participants. The study started on 2022-06-10. Estimated completion is 2023-10-11.
What interventions are being tested in trial NCT05540080?
The interventions under investigation include: BTL-899 (DEVICE).
Who is sponsoring clinical trial NCT05540080?
This trial is sponsored by BTL Industries, which has 40 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.